Original title: Global experts gather in Star City, and the 2025 academic conference on Alzheimer’s disease kicked off on August 9.
Red Net Moment News August 8 th(Reporter Hu Fang correspondent Kun Wang) The "2025 Healthy Bridge-International Academic Conference on Alzheimer’s Harmo’s Disease and Related Diseases", which has attracted worldwide attention in brain science, will open in Changsha, Hunan Province on August 9. This three-day international academic event will bring together Nobel Prize-nominated scholars, academicians, clinical experts and industry leaders from five continents to conduct in-depth exchanges and frontier collisions around the prevention, diagnosis, treatment, care and scientific research innovation of Alzheimer’s disease and related cognitive impairment diseases, and jointly explore new paths of global cooperation.
This conference is jointly sponsored by China Alzheimer’s Harmo Disease Prevention and Control Association and other authoritative organizations, gathering the world’s top wisdom, and the topics are closely related to the pulse of the times. Experts attending the meeting will discuss the latest breakthrough theory in the research of pathogenic proteins (such as Aβ, Tau protein) in depth, and point out the direction for the next generation of targeted drug research and development.
International authoritative scholars will bring the latest data of anti-Aβ monoclonal antibody therapy (such as Lecanemab, Donanemab) in early intervention, and the potential prospect of non-invasive intervention strategies such as convenient oral medicine HMTM. The integrated application of artificial intelligence and big data is another major focus. The early screening and risk prediction model based on multi-dimensional biomarkers is expected to greatly advance the early warning window. In addition, the characteristic intervention models and governance experiences from Latin America, Greece, Australia and other places will also be shared wonderfully, showing the diversity and vitality of global collaboration.
China’s scientific research and industrial strength will shine brilliantly on the conference stage. Team China will present revolutionary non-invasive urine and blood early screening technology, high-precision AI multimodal diagnosis model, innovative cognitive digital therapy platform, the latest progress of stem cell therapy in related fields, and original discovery of new pathogenic targets. The achievements of modernization of traditional Chinese medicine are also worth looking forward to.
It is worth mentioning that Qian Kang Science and Technology, an enterprise in Yuhua Economic Development Zone, became the co-organizer of this academic conference because of its contribution and industry influence in the field of Alzheimer’s disease. Its research and development of "urine amyloid β-protein test kit" is the only urine screening product in the world, and it has won 5 international patents alone.
The convening of this conference not only built a high-level communication platform for the global prevention and treatment of Alzheimer’s disease, but also showed Changsha’s innovative vitality in biomedicine and big health industry. Traditional Chinese medicine enterprises represented by Zhuhaitang Group and Borui Medicine in Yuhua Economic Development Zone, as well as cutting-edge medical technology companies such as Qian Kang Science and Technology and Lanwei Medicine, are promoting the innovative development of cognitive impairment prevention technology through the deep integration of Industry-University-Research. With the continuous improvement of the "basic research-clinical transformation-industrial application" chain, Changsha is becoming an important hub for global brain health research cooperation and achievement transformation, contributing to the wisdom of China and the strength of Hunan to meet the challenge of aging. (Hu Fang Kun Wang)
关于作者